Karyopharm Therapeutics Inc. (KPTIQ)
OTCMKTS · Delayed Price · Currency is USD
0.0250
-0.0089 (-26.25%)
At close: Nov 20, 2026
Karyopharm Therapeutics Market Cap
Karyopharm Therapeutics has a market cap or net worth of $567.04 thousand as of November 20, 2026. It is the 50,221st most valuable company in the world and the 6,817th biggest in the United States. Its market cap has decreased by 99.44% in one year.
Market Cap
567.04K
Enterprise Value
263.99M
Revenue
146.62M
Global Rank
Country Rank
#6,817 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since November 7, 2013, Karyopharm Therapeutics's market cap has decreased from 459.10M to 567.04K, a decrease of -99.88%. That is a compound annual growth rate of -40.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 567.04K | -99.58% |
| Dec 31, 2025 | 134.76M | 57.91% |
| Dec 31, 2024 | 85.34M | -13.86% |
| Dec 29, 2023 | 99.07M | -74.26% |
| Dec 30, 2022 | 384.92M | -20.76% |
| Dec 31, 2021 | 485.77M | -57.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AXIM Biotechnologies | 1.17M |
| Nymox Pharmaceutical | 1.14M |
| Avenue Therapeutics | 988.49K |
| ProtoKinetix | 823.26K |
| Protagenic Therapeutics | 755.67K |
| Helix BioMedix | 739.29K |
| SQZ Biotechnologies Company | 707.79K |
| Neon Bloom | 658.01K |